KAMADA Current Valuation

<div class='circular--portrait' style='background:#008000;color: #f8f8f8;font-size:3em;padding-top: 38px;;'>KMD</div>
KMDA -- Israel Stock  

ILA 2,722  148.00  5.16%

KAMADA current valuation fundamental analysis lookup allows you to check this and other indicators for KAMADA or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Current Valuation

 
Refresh
The current year Current Ratio is expected to grow to 6.14, whereas Net Current Assets as percentage of Total Assets are expected to decline to 57.09.

KAMADA Current Valuation Analysis

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

  Earnings Before Interest Taxes and Depreciation Amortization EBITDA

Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
More About Current Valuation | All Equity Analysis

Current KAMADA Current Valuation

1.06 B

KAMADA Distress Driver Correlations

About Current Valuation

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition

  Net Income

In accordance with recently published financial statements KAMADA has Current Valuation of 1.06 B. This is 92.62% lower than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?Specialty & Generic industry, The Current Valuation for all stocks is 93.62% higher than the company.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

KAMADACurrent Valuation Drivers

2014201520162017201820192020 (projected)
Revenue Per Employee235.31 K219.14 K204.99 K248.97 K280.56 K296.47 K257.28 K
PPandE Turnover3.293.253.554.344.565.134.36
Receivables Turnover3.433.113.33.823.74.614.72
Inventory Turnover2.082.372.092.153.032.92.14
Operating Margin(16.152818)(16.341945)(7.072806)7.2416.8217.9122.8
Return on Investment(11.828228)(14.226296)(7.762686)9.3118.7817.8919.3
Cash Flow Per Share(0.275588)(0.383841)0.0520480.0896110.2617190.68320.7372
Revenue to Assets0.59650.68540.77730.84210.82880.73180.6884
Quick Ratio2.322.331.852.553.413.032.64
Asset Turnover0.54980.63230.76640.92720.87980.81550.7461
Current Ratio3.143.512.833.34.74.396.14
Debt to Equity Ratio0.0931640.0025930.026610.022170.0113730.042474.6
EBITDA Margin(11.482446)(10.529854)(2.157586)10.421.020.8722.52
Gross Margin21.1722.627.9431.2136.2339.1132.87
Profit Margin(18.592838)(16.121649)(8.688415)6.7119.4817.4918.88
Sales per Share1.981.932.122.712.843.152.62
Inventories25.42 M26.34 M25.59 M21.07 M29.32 M43.17 M46.58 M
Receivables19.87 M25.08 M21.79 M31.97 M29.9 M25.24 M22.64 M
Accounts Payable20.57 M20.98 M21.89 M23.86 M22.55 M30.64 M25.02 M
Total Assets119.14 M101.99 M99.7 M122.11 M138.12 M173.8 M107 M
Current Assets97.19 M80.59 M77.08 M96.88 M110.89 M143.56 M85 M
Cash and Equivalents14.55 M5.05 M9.97 M12.68 M18.09 M42.66 M66.83 M
Shareholders Equity80.42 M72.51 M66.74 M89.49 M112.38 M135.32 M146 M

KAMADA Fundamentals

About KAMADA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze KAMADA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KAMADA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KAMADA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.

 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page